Article PDF
References
Nakamura T, Inoue T, Suzuki T, et al: Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertens Res 2008; 31: 841–850.
Ludwig M, Stapff M, Ribeiro A, et al: Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 2002; 24: 1175–1193.
Tedesco MA, Natale F, Calabrò R : Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. J Clin Hypertens (Greenwich) 2006; 8: 634–641.
Olsen MH, Wachtell K, Neland K, et al: Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press 2005; 14: 177–183.
Sonoda M, Aoyagi T, Takenaka K, Uno K, Nagai R : A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors. Int Heart J 2008; 49: 95–103.
Uchiyama-Tanaka Y, Mori Y, Kishimoto N, et al: Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension. Kidney Blood Press Res 2005; 28: 111–116.
Ariff B, Zambanini A, Vamadeva S, et al: Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke 2006; 37: 2381–2384.
Ono H, Minatoguchi S, Watanabe K, et al: Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res 2008; 31: 271–279.
Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H : Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers. Am J Nephrol 2006; 26: 462–468.
Tomás JP, Moya JL, Barrios V, et al: Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens 2006; 24: 2109–2114.
Okura T, Watanabe S, Kurata M, et al: Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension. Clin Exp Hypertens 2008; 30: 415–422.
Kosch M, Levers A, Lang D, et al: A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension. Nephrol Dial Transplant 2008; 23: 2280–2285.
Mörtsell D, Malmqvist K, Held C, Kahan T : Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med 2007; 261: 472–479.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ntaios, G., Savopoulos, C. & Hatzitolios, A. Telmisartan and Carotid Intima-Media Thickness Regression: A Class Effect of Angiotensin-Receptor Blockers?. Hypertens Res 31, 2187–2188 (2008). https://doi.org/10.1291/hypres.31.2187
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.2187